FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study
FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study have?
FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study has 62 citations in the OpenAlex counts ScholarIQ stores.
When was FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study published?
FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study has 2017 year in the ScholarIQ index.
What is the open-access status of FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study?
FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study has bronze oa status in the ScholarIQ index.
What is the DOI of FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study?
The DOI for FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study is on the source record.
What is the PMID of FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study?
The PMID for FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study is on the source record.
What is the OpenAlex record for FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study?
The OpenAlex for FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study is on the source record.